Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Zhou, Li  [Clear All Filters]
2023
Li Z, Li J, Wei Y, Zou W, Vidjro OEwi, Wang J, Zhou L, Zhu Y, Ma T. aBLA and pBLA Projections of Cell Type-Specific D1 Neurons from the mPFC Differentially Control Alcohol-Seeking Behavior. Biol Psychiatry. 2023.
Jin S, Song Y, Zhou L, Jiang W, Qin L, Wang Y, Yu R, Liu Y, Diao Y, Zhang F, et al. Depletion of CUL4B in macrophages ameliorates diabetic kidney disease via miR-194-5p/ITGA9 axis. Cell Rep. 2023;42(6):112550.
Fan M, Tong P, Yan L, Li T, Ren J, Huang J, Du W, Zhou L, Shan L. Detrimental alteration of mesenchymal stem cells by an articular inflammatory microenvironment results in deterioration of osteoarthritis. BMC Med. 2023;21(1):215.
Lv J, Zhou Y, Zhou N, Wang Z, Chen J, Chen H, Wang D, Zhou L, Wei K, Zhang H, et al. Epigenetic modification of locus dictates immune recognition of nascent tumorigenic cells. Sci Transl Med. 2023;15(681):eabq6024.
Chen J, Liu Y, Zhang J, Yang Y, Liang H, Li T, Yan L, Zhou L, Shan L, Wang H. External Application of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Hyaluronic Acid Gel Repairs Foot Wounds of Types I and II Diabetic Rats Through Paracrine Action Mode. Stem Cells Transl Med. 2023.
Duan L, Du S, Wang X, Zhou L, Liu Q, Li J. Glial cell line-derived neurotrophic factor (GDNF) is essential for colonization and expansion of turbot (Scophthalmus maximus) germ cells in recipients and in vitro culture. Theriogenology. 2023;214:1-9.
Bershteyn M, Bröer S, Parekh M, Maury Y, Havlicek S, Kriks S, Fuentealba L, Lee S, Zhou R, Subramanyam G, et al. Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy. Cell Stem Cell. 2023;30(10):1331-1350.e11.
Li X, Guo L, Chen J, Liang H, Liu Y, Chen W, Zhou L, Shan L, Wang H. Intravenous injection of human umbilical cord-derived mesenchymal stem cells ameliorates not only blood glucose but also nephrotic complication of diabetic rats through autophagy-mediated anti-senescent mechanism. Stem Cell Res Ther. 2023;14(1):146.
Zhou L, Wu D, Zhou Y, Wang D, Fu H, Huang Q, Qin G, Chen J, Lv J, Lai S, et al. Publisher Correction: Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1. Nat Immunol. 2023.
Li R, Zhang D, Ren B, Cao S, Zhou L, Xiong Y, Sun Q, Ren X. Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancer. Bull Cancer. 2023.
Marks ME, Botta RKrishna, Abe R, Beachkofsky TM, Boothman I, Carleton BC, Chung W-H, Cibotti RR, Dodiuk-Gad RP, Grimstein C, et al. Updates in SJS/TEN: collaboration, innovation, and community. Front Med (Lausanne). 2023;10:1213889.
Zhang X, Gale RPeter, Liu B, Huang J, Zhang Y, Du X, Weng J, Li W, Xu N, Liu X, et al. Validation of the imatinib-therapy failure model. Leukemia. 2023.
Lv J, Liu X, Zhou Y, Cheng F, Chen H, Li S, Wang D, Zhou L, Wang Z, Zhou N, et al. YAP Inactivation by Soft Mechanotransduction Relieves MAFG for Tumor Cell Dedifferentiation. Research (Wash D C). 2023;6:0215.

Pages